Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
China Medical Systems Inc is a specialty pharma company. The company manufactures various dosage forms such as powder, oral solution, small-volume injections, tablets, hard capsules, and others. Its product portfolio includes Plendil; Deanxit; Salofalk; Augentropfen Stulln Mono; Combizym; Yinuoshu; Xidakang; Imdur; Elcitonin; YinlianQinggan Granules; Nuodikang Capsules; Hirudoid and others.
Shenzhen, China, People's Republic of